Coloplast A/S (CLPBF)
OTCMKTS · Delayed Price · Currency is USD
96.80
+0.20 (0.21%)
Aug 29, 2025, 9:31 AM EDT
Coloplast Market Cap
Coloplast has a market cap or net worth of $21.63 billion as of August 29, 2025. Its market cap has decreased by -27.10% in one year.
Market Cap
21.63B
Enterprise Value
25.31B
Revenue
4.39B
Ranking
n/a
PE Ratio
33.71
Stock Price
$96.80
Market Cap Chart
Since November 17, 1997, Coloplast's market cap has increased from 891.72M to 21.63B, an increase of 2,325.19%. That is a compound annual growth rate of 12.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 21.63B | -12.21% |
| Dec 30, 2024 | 24.63B | -4.23% |
| Dec 29, 2023 | 25.72B | 3.77% |
| Dec 30, 2022 | 24.79B | -33.55% |
| Dec 30, 2021 | 37.30B | 14.26% |
| Dec 30, 2020 | 32.65B | 23.84% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 832.17M |
| Elite Pharmaceuticals | 734.61M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 655.63M |
| Northwest Biotherapeutics | 448.50M |
| CytoDyn | 376.00M |
| American Oncology Network | 343.87M |